Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers ...

Maravai LifeSciences Holdings on Monday said that it has appointed Bernd Brust as chief executive officer, effective immediately.

Maravai LifeSciences Holdings, Inc.'s stock has plummeted from $60 to $2.1 per share due to declining COVID vaccine-related revenues, but I am upgrading from a "Sell" to a "Hold" rating.

Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...

SAN DIEGO, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and ...

Throughout the last three months, 4 analysts have evaluated Maravai LifeSciences (NASDAQ:MRVI), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a ...

and 2023 stock-based compensation is expected to be in the range of $34.0 million to $36.0 million. Maravai LifeSciences NewsMORE Related Stocks ...

Throughout the last three months, 5 analysts have evaluated Maravai LifeSciences MRVI, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table ...

Shares of Maravai LifeSciences (NASDAQ:MRVI) plunged 39% Friday, the day after the company issued a Q3 earnings report and ...

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has ...

Maravai LifeSciences reported Q1 2025 revenue of $46.9 million and a net loss of $52.9 million. Maravai reported first quarter revenue of $46.9 million, which exceeded its guidance range ...

The latest price target for Maravai LifeSciences (NASDAQ:MRVI) was reported by Morgan Stanley on March 25, 2025. The analyst firm set a price target for $5.00 expecting MRVI to rise to within 12 ...